Stanley G. Rockson, MD
Publications
- Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J. 2013; (3): 1114-26
- The aging lymphatics become more mature. Lymphat Res Biol. 2013; (1): 1
- Angiogenesis, lymphangiogenesis, and inflammation. Lymphat Res Biol. 2012; (4): 151
- Cancer is part of the lymphatic continuum. Lymphat Res Biol. 2012; (3): 95
- Experimental lymphedema: can cellular therapies augment the therapeutic potential for lymphangiogenesis? J Am Heart Assoc. 2012; (4): e003400
- Lack of significant interactions between clopidogrel and proton pump inhibitor therapy: meta-analysis of existing literature. Dig Dis Sci. 2012; (5): 1304-13
- Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel. PLoS One. 2012; (12): e52021
- Reflections on a decade of lymphatic research and biology. Lymphat Res Biol. 2012; (1): 1
- The lymphatic biology of aging. Lymphat Res Biol. 2012; (2): 45
- Update on the biology and treatment of lymphedema. Curr Treat Options Cardiovasc Med. 2012; (2): 184-92
- Animal models for the mechanistic study of systemic lymphangiomatosis. Lymphat Res Biol. 2011; (4): 195-9
- Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair. Am J Pathol. 2010; (6): 3202-14
- Causes and consequences of lymphatic disease. Ann N Y Acad Sci. 2010: E2-6
- Current concepts and future directions in the diagnosis and management of lymphatic vascular disease. Vasc Med. 2010; (3): 223-31
- Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS One. 2009; (12): e8380
- Appropriate secondary prevention of acute atherothrombotic events and strategies to improve guideline adherence. Postgrad Med. 2009; (1): 25-39
- Lymphatic research: past, present, and future. Lymphat Res Biol. 2009; (4): 183-7
- The unique biology of lymphatic edema. Lymphat Res Biol. 2009; (2): 97-100
- Therapeutic responses to exogenous VEGF-C administration in experimental lymphedema: immunohistochemical and molecular characterization. Lymphat Res Biol. 2009; (1): 47-57
- Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci. 2008: 50-74
- Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol. 2008; (10): 799-806
- Estimating the population burden of lymphedema. Ann N Y Acad Sci. 2008: 147-54
- Gorham's disease: an osseous disease of lymphangiogenesis? Ann N Y Acad Sci. 2008: 203-5
- Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease. Lymphat Res Biol. 2008; (3-4): 181-9
- The clinical spectrum of lymphatic disease. Ann N Y Acad Sci. 2008: 155-84
- The lymphatic continuum revisited. Ann N Y Acad Sci. 2008: ix-x
- The role of the lymphatic circulation in the natural history and expression of cardiovascular disease. Int J Cardiol. 2008; (3): 309-17
- Biomarkers of lymphatic function and disease: state of the art and future directions. Mol Diagn Ther. 2007; (4): 227-38
- Rapid diagnosis of myocardial injury with troponin T and CK-MB relative index. Mol Diagn Ther. 2007; (2): 109-16
- Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes. Cardiovasc Drugs Ther. 2007; (5): 375-88
- A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema [ISRCTN76522412]. BMC Cancer. 2006: 84
- Addressing the unmet needs in lymphedema risk management. Lymphat Res Biol. 2006; (1): 42-6
- An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs. 2006; (6): 363-70
- Indirect magnetic resonance lymphangiography to assess lymphatic function in experimental murine lymphedema. Lymphat Res Biol. 2006; (4): 211-6
- Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med. 2006; (7): e254
- Literature watch. Lymphat Res Biol. 2006; (1): 57-61
- Lymphedema. Curr Treat Options Cardiovasc Med. 2006; (2): 129-36
- The lymphatic continuum continues. Lymphat Res Biol. 2006; (1): 1-2
- Validation of a new technique for the quantitation of edema in the experimental setting. Lymphat Res Biol. 2006; (3): 153-8
- Literature watch. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Lymphat Res Biol. 2005; (4): 263-7
- Lymphedema therapy in the vascular anomaly patient: therapeutics for the forgotten circulation. Lymphat Res Biol. 2005; (4): 253-5
- The lymphatic biology of Kaposi's sarcoma. Lymphat Res Biol. 2005; (1): 25-35
- Therapeutics for lymphatic disease: the role of the pharmaceutical and biotechnology sector. Lymphat Res Biol. 2005; (3): 103-4
- Treprostinil for the treatment of severe digital necrosis in systemic sclerosis. Vasc Med. 2005; (1): 29-32
- Benefits of resident work hours regulation. Ann Intern Med. 2004; (10): 816-7
- Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J Am Coll Cardiol. 2004; (6): 929-35
- How can lymphatic research influence lymphatic education? Lymphat Res Biol. 2004; (2): 67-8
- Lymphatic biology and disease: is it being taught? Who is listening? Lymphat Res Biol. 2004; (2): 86-95
- The elusive adipose connection. Lymphat Res Biol. 2004; (3): 105-6
- The potential for molecular treatment strategies in lymphatic disease. Lymphat Res Biol. 2004; (4): 173-81
- Tumors, wounds, and lymph. Lymphat Res Biol. 2004; (4): 153-4
- Animal models for the study of lymphatic insufficiency. Lymphat Res Biol. 2003; (2): 159-69
- Coronary restenosis: a review of mechanisms and management. Am J Med. 2003; (7): 547-53
- Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A. 2003; (19): 10623-8
- Endothelial dysfunction: clinical strategies for treating oxidant stress. Am Heart J. 2003; (2): 218-26
- Immune traffic: a functional overview. Lymphat Res Biol. 2003; (3): 219-34
- The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003; (1): 43-57
- Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer. 2002; (11): 2260-7
- Diagnosis and treatment of concomitant venous obstruction in patients with secondary lymphedema. J Vasc Interv Radiol. 2002; (8): 799-803
- Lymphedema-lymphangiectasia-mental retardation (Hennekam) syndrome: a review. Am J Med Genet. 2002; (4): 412-21
- Myocarditis in systemic lupus erythematosus. Am J Med. 2002; (5): 419-23
- Preclinical models of lymphatic disease: the potential for growth factor and gene therapy. Ann N Y Acad Sci. 2002: 64-75; discussion 76-9
- Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity. Nucl Med Commun. 2002; (12): 1171-5
- The lymphatic continuum: the past, present, and exciting future of lymphatic research. Ann N Y Acad Sci. 2002: 1-4; discussion 35-8
- The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis. 2002; (1): 91-102
- Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 2002; (14): 1985-7
- Angiogenesis and the ischaemic heart. Eur Heart J. 2001; (11): 903-18
- Feasibility and reliability of rapid diagnosis of myocardial infarction. Am J Med Sci. 2001; (6): 339-44
- Formulating clinical strategies for angiotensin antagonism: a review of preclinical and clinical studies. Am J Med. 2001; (6): 471-80
- Lymphedema. Am J Med. 2001; (4): 288-95
- Benefits of lipid-lowering agents in stroke and coronary heart disease: pharmacoeconomics. Curr Atheroscler Rep. 2000; (2): 144-50
- Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med. 2000; (4): 296-300
- Lymphedema. Curr Treat Options Cardiovasc Med. 2000; (3): 237-242
- Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin). Circulation. 2000; (19): 2322-4
- Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy. Circulation. 2000; (5): 591-6
- Fibroblast growth factor as therapy for critical limb ischemia: a case report. Vasc Med. 1999; (2): 89-91
- Images in vascular medicine. Complex lower extremity edema in a young woman. Vasc Med. 1999; (4): 273-4
- Lutetium Texaphyrin: A New Therapeutic Tool for Human Atherosclerosis. Curr Treat Options Cardiovasc Med. 1999; (3): 199-202
- Lymphoscintigraphic manifestations of Hennekam syndrome--a case report. Angiology. 1999; (12): 1017-20
- American Cancer Society Lymphedema Workshop. Workgroup III: Diagnosis and management of lymphedema. Cancer. 1998; (12 Suppl American): 2882-5
- Images in vascular medicine. Lymphoscintigraphy in congenital lymphedema. Vasc Med. 1998; (4): 327-8
- Images in vascular medicine. Phlegmasia coerulea dolens--venous gangrene. Vasc Med. 1998; (1): 29-31
- Lymphedema: classification, diagnosis and therapy. Vasc Med. 1998; (2): 145-56
- Myocardial ischemia and infarction due to multiple coronary-cameral fistulae: two case reports and review of the literature. Cathet Cardiovasc Diagn. 1998; (2): 179-83
- Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options. Adv Intern Med. 1998: 253-77
- Precipitating factors in lymphedema: myths and realities. Cancer. 1998; (12 Suppl American): 2814-6
- Limitations of Quantitative Coronary Angiography Guidebook to Coronary Endovascular Diagnostic Techniques. Geschwind HJ, Kern MJ, Editors. Futura Publications, Mt. Kisko, NY,. 1997
- Lymphedema: A review of the relevant anatomy and physiology of the lymphatics. Vascular Medicine. 1997; (2): 321-6
- Lymphedema: anatomy, physiology and pathogenesis. Vasc Med. 1997; (4): 321-6
- A novel therapy for lymphedema complicated by lymphorrhea. Vasc Med. 1996; (4): 247-50
- Pregnancy-associated group B streptococcal endocarditis: a report of two fatal cases. Obstet Gynecol. 1985; (3 Suppl): 44S-47S
- Purification and characterization of the mammalian beta 2-adrenergic receptor. Biochemistry. 1983; (3): 660-8
- An antiidiotypic antibody that recognizes the beta-adrenergic receptor. J Clin Invest. 1982; (5): 1147-54
- Cellular mechanisms of impaired adrenergic responsiveness in neonatal dogs. J Clin Invest. 1981; (2): 319-27
- Anti-alprenolol antibodies in the rabbit. A new probe for the study of beta-adrenergic receptor interaction. Circ Res. 1980; (6): 808-13
- Plasma dopamine-beta-hydroxylase in the diagnosis of neuroblastoma. Cancer. 1976; (1): 386-9
- Plasma dopamine-beta-hydroxylase activity in oral contraceptive hypertension. Circulation. 1975; (5): 916-23
- Lesch-Nyhan syndrome: evidence for abnormal adrenergic function. Science. 1974; (4167): 934-5
- Solitary renal cyst with segmental ischemia and hypertension. J Urol. 1974; (5): 550-2
Help
Trial Administration